These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 12770987)
1. The effect of topical glaucoma medications evaluated by perimetry. Lin JC; Samuel F; Katz LJ; Spaeth GL; Hoop J; Cantor LB Br J Ophthalmol; 2003 Jun; 87(6):792. PubMed ID: 12770987 [No Abstract] [Full Text] [Related]
2. The one-month effects of topical betaxolol, dorzolamide and apraclonidine on ocular blood flow velocities in patients with newly diagnosed primary open-angle glaucoma. Avunduk AM; Sari A; Akyol N; Oztürk O; Kapicioglu Z; Erdöl H; Imamoglu HI Ophthalmologica; 2001; 215(5):361-5. PubMed ID: 11528262 [TBL] [Abstract][Full Text] [Related]
3. The effect of topical antiglaucoma drugs on the results of high-pass resolution perimetry. Martin-Boglind LM; Graves A; Wanger P Am J Ophthalmol; 1991 Jun; 111(6):711-4. PubMed ID: 2039041 [TBL] [Abstract][Full Text] [Related]
4. New topical medications in the treatment of glaucoma. Gandham SB J Ophthalmic Nurs Technol; 1997; 16(6):290-1. PubMed ID: 9460417 [TBL] [Abstract][Full Text] [Related]
5. Effects of topical 0.5% levobunolol alone or in association with 2% dorzolamide compared with a fixed combination of 0.5% timolol and 2% dorzolamide on intraocular pressure and heart rate in dogs without glaucoma. Scardillo A; Pugliese M; De Majo M; Niutta PP; Pugliese A Vet Ther; 2010; 11(3):E1-6. PubMed ID: 20960417 [TBL] [Abstract][Full Text] [Related]
6. Update in glaucoma: the new pharmacotherapies. Dorzolamide hydrochloride. Gould LF Can J Ophthalmol; 1998 Aug; 33(5):253-4; discussion 257-8. PubMed ID: 9740951 [No Abstract] [Full Text] [Related]
7. [Current trend of glaucoma medication with various eye drops]. Fukuchi T Nippon Ganka Gakkai Zasshi; 2013 Oct; 117(10):781-3. PubMed ID: 24354261 [No Abstract] [Full Text] [Related]
8. Effect of topical pressure-lowering medication on prevention of intraocular pressure spikes after intravitreal injection. El Chehab H; Le Corre A; Agard E; Ract-Madoux G; Coste O; Dot C Eur J Ophthalmol; 2013; 23(3):277-83. PubMed ID: 23161177 [TBL] [Abstract][Full Text] [Related]
9. [Clinical investigation: the intraocular pressure-lowering efficacy and safety of brinzolamide combined with betaxolol]. Minbin Y; Fang M; Ge J; Huang S Yan Ke Xue Bao; 2005 Dec; 21(4):137-40, 152. PubMed ID: 17162869 [TBL] [Abstract][Full Text] [Related]
13. Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma. Morrison JC; Nylander KB; Lauer AK; Cepurna WO; Johnson E Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):526-31. PubMed ID: 9501862 [TBL] [Abstract][Full Text] [Related]
14. Drugs and glaucoma. Soll DB; Saxon AM Am Fam Physician; 1986 Jul; 34(1):181-5. PubMed ID: 2873739 [No Abstract] [Full Text] [Related]
15. [Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections]. El Chehab H; Le Corre A; Giraud JM; Ract-Madoux G; Swalduz B; Dot C J Fr Ophtalmol; 2012 Oct; 35(8):614-21. PubMed ID: 22832030 [TBL] [Abstract][Full Text] [Related]
16. [Assessment of visual function under treatment with topical antiglaucoma agents and systemic vasodilators. Clinical study on glaucoma patients]. Popa SA; Bucătariu PM; Azoicăhi D; Costin D; Manole A; Matei M; Merchez M Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):455-9. PubMed ID: 21870740 [TBL] [Abstract][Full Text] [Related]
17. Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension. Balfour JA; Wilde MI Drugs Aging; 1997 May; 10(5):384-403. PubMed ID: 9143858 [TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of dorzolamide as added therapy in glaucoma patients with maximum tolerated drug therapy. A pilot study]. Denk PO; Knorr M; Kriegerowski M; Thiel HJ Klin Monbl Augenheilkd; 1997 Jun; 210(6):360-4. PubMed ID: 9333661 [TBL] [Abstract][Full Text] [Related]
19. [Intraocular pressure after ND: YAG laser capsulotomy in pseudophakic patients with glaucoma]. Sesar A; Petric I; Sesar I; Lacmnovic-Loncar V; Jurisić D; Tomić Z; Mandić Z Acta Med Croatica; 2006; 60(2):109-12. PubMed ID: 16848199 [TBL] [Abstract][Full Text] [Related]
20. Betaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric glaucoma: a randomized clinical trial. Plager DA; Whitson JT; Netland PA; Vijaya L; Sathyan P; Sood D; Krishnadas SR; Robin AL; Gross RD; Scheib SA; Scott H; Dickerson JE; J AAPOS; 2009 Aug; 13(4):384-90. PubMed ID: 19683191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]